Continuous Prophylaxis with Recombinant Von Willebrand Factor in People with Clinically Severe Congenital Types 1 and 2 Von Willebrand Disease in a Real-World Setting: Interim Analysis of ATHN 9, a Natural History Study for People with Severe VWD

Author(s):
Robert F Sidonio, Jr., Angela C Weyand, Tammuella Chrisentery-Singleton, Martin Chandler, Carol Fedor, Priscilla Driscoll-Shempp, Michelle Kirby, Jorge Caicedo
Publication:
Blood
Date:
November 5, 2024
Topics:
VWD, Von Willebrand Disease

Can’t find what you’re looking for?
Please contact support@athn.org for assistance.